Matches in Wikidata for { <http://www.wikidata.org/entity/Q64352900> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q64352900 description "clinical trial" @default.
- Q64352900 description "ensayu clínicu" @default.
- Q64352900 description "klinisch onderzoek" @default.
- Q64352900 description "клінічне випробування" @default.
- Q64352900 name "Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)" @default.
- Q64352900 type Item @default.
- Q64352900 label "Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)" @default.
- Q64352900 prefLabel "Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)" @default.
- Q64352900 P1050 Q64352900-3661B14E-7954-407A-9DAF-AB434C6D2491 @default.
- Q64352900 P1132 Q64352900-B70D8B09-4EDA-4C35-B2B2-5EBFE9ECD603 @default.
- Q64352900 P131 Q64352900-A23BF175-D9A1-44FB-B84D-BD6CA52F9D86 @default.
- Q64352900 P1476 Q64352900-3F0EF4B4-D094-45DB-B7AE-C736FACC37D7 @default.
- Q64352900 P17 Q64352900-14F97979-E6A8-460A-A948-F6EA1E674AF3 @default.
- Q64352900 P17 Q64352900-28972BFA-B1BF-4C9F-8D61-EFDA8A1CAA92 @default.
- Q64352900 P17 Q64352900-72C762FF-636E-42D0-8017-0BC62E154E2D @default.
- Q64352900 P17 Q64352900-80F4E846-592A-42D8-AE9B-11C71F2632AF @default.
- Q64352900 P17 Q64352900-C126298C-F49D-4851-9CD5-F7BB6B616892 @default.
- Q64352900 P1813 Q64352900-0D561C09-7409-45E8-B96E-29ECC9F3B340 @default.
- Q64352900 P2899 Q64352900-4079B34B-5F07-404A-B494-309309FB01D6 @default.
- Q64352900 P3098 Q64352900-CD110AFE-36EB-4E2E-859A-16E34A0CFF99 @default.
- Q64352900 P31 Q64352900-7BADA0F9-48E2-46FA-88E3-31D4DF491C20 @default.
- Q64352900 P4844 Q64352900-B8304211-5345-4F9F-B490-06828E38E977 @default.
- Q64352900 P580 Q64352900-7B759164-0AB8-4E6C-9FC1-80609896F7CC @default.
- Q64352900 P582 Q64352900-8AEB7BF0-39FE-402D-B2DB-173A60420FEB @default.
- Q64352900 P6099 Q64352900-649FA853-3669-4AF3-A2E5-2C59D7A84465 @default.
- Q64352900 P6153 Q64352900-8BCA8AD8-B110-4A64-81B9-4092E4553796 @default.
- Q64352900 P8363 Q64352900-0517C0B9-76A0-473D-AB25-298879C0060F @default.
- Q64352900 P859 Q64352900-64DA313A-BC61-40D8-B13C-1AB2BACE66FE @default.
- Q64352900 P1050 Q18554884 @default.
- Q64352900 P1132 "+252" @default.
- Q64352900 P131 Q8646 @default.
- Q64352900 P1476 "A Randomized Double-masked, Phase III Study Assessing Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Visual Impairment Due to Macular Edema (ME) Secondary to Central Retinal Vein Occlusion (CRVO) [Camellia]" @default.
- Q64352900 P17 Q252 @default.
- Q64352900 P17 Q668 @default.
- Q64352900 P17 Q865 @default.
- Q64352900 P17 Q881 @default.
- Q64352900 P17 Q928 @default.
- Q64352900 P1813 "Camellia" @default.
- Q64352900 P2899 "+18" @default.
- Q64352900 P3098 "NCT01976312" @default.
- Q64352900 P31 Q30612 @default.
- Q64352900 P4844 Q414270 @default.
- Q64352900 P580 "2013-11-12T00:00:00Z" @default.
- Q64352900 P582 "2016-03-14T00:00:00Z" @default.
- Q64352900 P6099 Q42824827 @default.
- Q64352900 P6153 Q507154 @default.
- Q64352900 P8363 Q78089383 @default.
- Q64352900 P859 Q507154 @default.